CALDER BIOSCIENCES INC has a total of 17 patent applications. It increased the IP activity by 700.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are NATIONWIDE CHILDRENS HOSPITAL INC, AVIR GREEN HILLS BIOTECHNOLOGY and GARCIA-SASTRE ADOLFO.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 5 | |
#3 | Australia | 3 | |
#4 | China | 1 | |
#5 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials | |
#6 | Climate change adaptation technologies | |
#7 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Marshall Christopher Patrick | 12 |
#2 | Mariani Roberto | 9 |
#3 | Bertuccioli Claudio | 6 |
#4 | Alff Peter Joseph | 6 |
#5 | Yondola Mark | 5 |
#6 | Marshall Christopher | 5 |
#7 | Gidwani Sonal | 5 |
#8 | Zomback Aaron | 5 |
#9 | Mclellan Jason Scott | 4 |
#10 | Yondola Mark Andrew | 2 |
Publication | Filing date | Title |
---|---|---|
AU2018313000A1 | Conformationally stabilized RSV pre-fusion F proteins | |
EP2846828A1 | Conformationally specific viral immunogens |